Overview

• Ariel García Furfaro declared for six hours before Judge Ernesto Kreplak, rejected any responsibility, alleged a conspiracy, and accused former associate Andrés Quinteros of deliberately introducing bacteria.
• He also faulted ANMAT for delayed alerts and said media and regulatory actions damaged his businesses, while insisting he would accept consequences if proven responsible.
• Laboratory analyses by ANLIS Malbrán confirmed contamination with Klebsiella pneumoniae, Klebsiella variicola, and Ralstonia mannitolilytica, and the Supreme Court’s medical forensics found the drug worsened the condition in 12 of the first 20 deaths reviewed.
• The probe centers on lots 31.202 and 31.244 produced in December and released in early January, with lot 31.202 comprising 154,530 ampoules distributed via Alpharma, Glamamed, Nueva Era and others after Hospital Italiano de La Plata first raised alarms.
• The case, which court filings link to up to 96 patient deaths, includes detention orders and ongoing statements from suspects, as the Ramallo quality manager declined to testify and lawmakers move to debate an investigative commission.